Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.

22 Jun, 2021 | 10:00h | UTC

Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline – Annals of Internal Medicine

Original guideline: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Commentary: Guideline issued on blood pressure management in CKD – ACP Internist

 


Expert analysis: the ever-growing role of coronary artery calcium in primary prevention.

22 Jun, 2021 | 09:54h | UTC

The Ever-Growing Role of Coronary Artery Calcium in Primary Prevention – American College of Cardiology

 

Commentary on Twitter

 


Risk of atrial fibrillation according to cancer type: a nationwide population-based study – Multiple myeloma showed a higher association with incident AF (aHR: 3.34; 95% CI: 2.98 to 3.75). Esophageal cancer showed the highest risk among solid cancers (aHR: 2.69; 95% CI: 2.45 to 2.95).

21 Jun, 2021 | 08:37h | UTC

Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study – JACC: CardioOncology

 

Commentary on Twitter

 


AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.

21 Jun, 2021 | 08:38h | UTC

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association – Circulation

Commentary: Arrhythmias and Autonomic Dysfunction in the Cancer Patient: Charting a New Path Into the Cardio-oncology Wilderness – American Heart Association

Top Things to Know: Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology – American Heart Association

 


Another meta-analysis supports aspirin withdrawal one to three months after percutaneous coronary intervention and continuation with P2Y12 inhibitor monotherapy.

18 Jun, 2021 | 08:22h | UTC

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials – The BMJ

Related: M-A: After an acute coronary syndrome treated with coronary stenting, dual antiplatelet therapy (DAPT) for 1 to 3 months followed by P2Y12 inhibitor monotherapy is associated with improved outcomes compared with traditional DAPT for 12 months.

 


Study commentary: a history of hypothermia for cardiac arrest, 2002-2021 (RIP).

18 Jun, 2021 | 08:20h | UTC

A history of hypothermia for cardiac arrest, 2002-2021 (RIP) – PulmCrit

Original study: RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.

 

Commentary on Twitter

 


Case series: clinical and cardiac magnetic resonance imaging findings of 4 cases of myocarditis following mRNA-based COVID-19 vaccination.

17 Jun, 2021 | 09:43h | UTC

Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings – JACC: Cardiovascular Imaging

Commentary: Possible Association Between COVID-19 Vaccine and Myocarditis – American College of Cardiology

Related: CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. AND Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. AND CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

 


Case series: 7 cases of myocarditis following mRNA-based COVID-19 vaccination.

17 Jun, 2021 | 09:45h | UTC

Myocarditis after BNT162b2 and mRNA-1273 Vaccination – Circulation

Commentary: Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients – News Medical

Related: CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. AND Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. AND CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

 


RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.

17 Jun, 2021 | 09:39h | UTC

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest – New England Journal of Medicine

News release: Induced hypothermia after cardiac arrest did not improve survival – Lund University

Infographic: The TTM2 Trial – CanadianEM

Commentary: Hypothermia or Normothermia after Cardiac Arrest – NEJM Resident 360

Video: TTM2 Results Presentation Livestream – Critical Care Reviews

 

Commentary on Twitter (thread – click for more)

 


Case series: symptomatic acute myocarditis in 7 adolescents following mRNA COVID-19 vaccination.

17 Jun, 2021 | 09:41h | UTC

Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination – Pediatrics

Related: CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. AND Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. AND CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

 


Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care.

16 Jun, 2021 | 08:29h | UTC

Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care – Journal of Primary Care & Community Health

 


Review: venous and arterial thromboembolism in patients with cancer.

16 Jun, 2021 | 08:20h | UTC

Venous and Arterial Thromboembolism in Patients With Cancer: JACCCardioOncology State-of-the-Art Review

Summary: Venous and Arterial Thromboembolism in Patients With Cancer – American College of Cardiology

 


AHA Scientific Statement: Mechanical Complications of Acute Myocardial Infarction.

16 Jun, 2021 | 08:21h | UTC

Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association – Circulation

 


M-A: Among patients with kidney failure treated with dialysis, mineralocorticoid receptor antagonists reduce cardiovascular and all-cause mortality without increasing the risk of hyperkalemia.

15 Jun, 2021 | 08:53h | UTC

Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Podcast | Dominate stable angina with the CardioNerds.

15 Jun, 2021 | 08:51h | UTC

#279 Dominate Stable Angina with the CardioNerds – The Curbsiders

 


WHO: More than 100 reasons to quit tobacco.

14 Jun, 2021 | 08:38h | UTC

More than 100 reasons to quit tobacco – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


M-A: Effect of ultrashort-acting betablockers on mortality in patients with sepsis with persistent tachycardia.

14 Jun, 2021 | 08:33h | UTC

Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials – CHEST

 


ESC Consensus Document: Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions.

14 Jun, 2021 | 08:31h | UTC

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) – European Heart Journal

Commentaries: Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI – TCTMD AND Periprocedural Myocardial Injury and MI Associated With PCI – American College of Cardiology

 


CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare.

11 Jun, 2021 | 08:28h | UTC

CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare – CNBC

See also: CDC plans “emergency meeting” on rare heart inflammation following COVID-19 vaccines – CBC News

Related: Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.

 


RCT: In patients with atrial fibrillation or mechanical heart valves treated with warfarin undergoing surgery, postoperative bridging treatment with low molecular weight heparin did not prevent major thromboembolism.

11 Jun, 2021 | 08:19h | UTC

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial – The BMJ

 

Commentary on Twitter

 


Antiarrhythmic drugs for atrial fibrillation in the outpatient setting: common clinical scenarios and pearls for the primary care clinician.

11 Jun, 2021 | 08:16h | UTC

Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician – Mayo Clinic Proceedings

 


More data suggests no cardiovascular benefit from Omega-3 supplementation – secondary analysis of STRENGHT trial did not show an association between achieved Omega-3 fatty acid levels and major adverse cardiovascular outcomes in patients with high cardiovascular risk.

8 Jun, 2021 | 09:19h | UTC

Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial – JAMA Cardiology

Original study: #AHA20 – Randomized trial: High-dose Omega-3 fatty acids did not reduce the risk of cardiac events in patients at high cardiovascular risk

Commentaries: Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events – American College of Cardiology

 


RCT: Heart-protecting drugs likely unnecessary for most breast cancer patients undergoing adjuvant treatment.

8 Jun, 2021 | 09:15h | UTC

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol – Circulation

Commentaries: Heart-protecting drugs likely unnecessary for many breast cancer patients – American College of Cardiology

 


Review: Management of patients with venous thromboembolism after the initial treatment period.

8 Jun, 2021 | 09:13h | UTC

Management of Patients With Venous Thromboembolism After the Initial Treatment Period – The Journal of the American Board of Family Medicine

 


RCT: No benefit from passive leg raising during cardiopulmonary resuscitation in out-of-hospital cardiac arrest.

4 Jun, 2021 | 10:28h | UTC

Clinical outcomes and safety of passive leg raising in out-of-hospital cardiac arrest: a randomized controlled trial – Critical Care

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.